4.7 Article

The anti-cancer effects of itraconazole in epithelial ovarian cancer

Related references

Note: Only part of the references are listed.
Review Oncology

Major clinical research advances in gynecologic cancer in 2014

Dong Hoon Suh et al.

JOURNAL OF GYNECOLOGIC ONCOLOGY (2015)

Article Oncology

Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer

Jeong-Won Lee et al.

INTERNATIONAL JOURNAL OF CANCER (2015)

Review Oncology

Gynecologic Cancer InterGroup (GCIG) Consensus Review for Uterine and Ovarian Carcinosarcoma

Dominique Berton-Rigaud et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2014)

Article Medicine, General & Internal

Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer

Robert A. Burger et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Medicine, General & Internal

A Phase 3 Trial of Bevacizumab in Ovarian Cancer

Timothy J. Perren et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Oncology

Cancer Statistics, 2010

Ahmedin Jemal et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2010)

Article Multidisciplinary Sciences

Cholesterol trafficking is required for mTOR activation in endothelial cells

Jing Xu et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Biochemistry & Molecular Biology

Inhibition of angiogenesis by the antifungal drug itraconazole

Curtis R. Chong et al.

ACS CHEMICAL BIOLOGY (2007)

Article Biochemistry & Molecular Biology

Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma

Premal H. Thaker et al.

NATURE MEDICINE (2006)

Article Multidisciplinary Sciences

Hedgehog signalling in prostate regeneration, neoplasia and metastasis

SS Karhadkar et al.

NATURE (2004)